Population characteristics by baseline PSA and age category
| Age at baseline PSA* . | Baseline PSA (ng/mL)† . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 0-0.9 . | 1.0-1.9 . | 2.0-2.9 . | 3.0-3.9 . | 4.0-9.9 . | ≥10.0 . | Total (%) . | ||||||
| <50 (%) | 5,176 (61.3) | 2,174 (25.7) | 631 (7.5) | 148 (1.8) | 202 (2.4) | 112 (1.3) | 8,443 (12.4) | ||||||
| 50-59 (%) | 5,781 (40.9) | 4,320 (30.6) | 1,819 (12.9) | 717 (5.1) | 1,027 (7.3) | 460 (3.3) | 14,124 (20.8) | ||||||
| 60-69 (%) | 4,921 (25.6) | 5,025 (26.1) | 3,033 (15.8) | 1,606 (8.3) | 3,174 (16.5) | 1,490 (7.7) | 19,249 (28.4) | ||||||
| ≥70 (%) | 4,219 (16.2) | 4,794 (18.4) | 3,659 (14.1) | 2,427 (9.3) | 6,151 (23.6) | 4,766 (18.3) | 26,016 (38.4) | ||||||
| Total (%) | 20,097 (29.6) | 16,313 (24.0) | 9,142 (13.5) | 4,898 (7.2) | 10,554 (15.6) | 6,828 (10.1) | 67,832 | ||||||
| Age at baseline PSA* . | Baseline PSA (ng/mL)† . | . | . | . | . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 0-0.9 . | 1.0-1.9 . | 2.0-2.9 . | 3.0-3.9 . | 4.0-9.9 . | ≥10.0 . | Total (%) . | ||||||
| <50 (%) | 5,176 (61.3) | 2,174 (25.7) | 631 (7.5) | 148 (1.8) | 202 (2.4) | 112 (1.3) | 8,443 (12.4) | ||||||
| 50-59 (%) | 5,781 (40.9) | 4,320 (30.6) | 1,819 (12.9) | 717 (5.1) | 1,027 (7.3) | 460 (3.3) | 14,124 (20.8) | ||||||
| 60-69 (%) | 4,921 (25.6) | 5,025 (26.1) | 3,033 (15.8) | 1,606 (8.3) | 3,174 (16.5) | 1,490 (7.7) | 19,249 (28.4) | ||||||
| ≥70 (%) | 4,219 (16.2) | 4,794 (18.4) | 3,659 (14.1) | 2,427 (9.3) | 6,151 (23.6) | 4,766 (18.3) | 26,016 (38.4) | ||||||
| Total (%) | 20,097 (29.6) | 16,313 (24.0) | 9,142 (13.5) | 4,898 (7.2) | 10,554 (15.6) | 6,828 (10.1) | 67,832 | ||||||